Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Nucleic Acid Therapeutics|April 24, 2012
Adenosine modification may be preferred for reducing siRNA immune stimulationRaymond V Fucini, Henry J Haringsma, Patricia Deng, et al.Nucleic Acid Therapeutics|March 10, 2012
In vivo activity and duration of short interfering RNAs containing a synthetic 5'-phosphateDenise M Kenski, Aarron T Willingham, Henry J Haringsma, et al.Nucleic Acids Research|January 19, 2012
mRNA knockdown by single strand RNA is improved by chemical modificationsHenry J Haringsma, Jenny J Li, Ferdie Soriano, et al.Journal of the American Chemical Society|May 27, 2011
Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNAHayden Peacock, Raymond V Fucini, Prasanna Jayalath, et al.Nucleic Acids Research|November 18, 2009
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivoDenise M Kenski, Abby J Cooper, Jenny J Li, et al.Nature Genetics|November 22, 2016
Inactivation of Capicua drives cancer metastasisRoss A Okimoto, Frank Breitenbuecher, Victor R Olivas, et al.Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.Nature Medicine|November 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancerKhyati N Shah, Roma Bhatt, Julia Rotow, et al.Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.Pageof 2